Women around the globe need to be aware of their cancer risks. The latest research published The Lancet medical journal finds that cancer deaths are predicted to rise 60 percent by the year 2030, according to PBS WGBH. These cancer deaths stem from both breast and cervical cancers with breast cancer deaths likely to double to 3.2 million by 2030. Cervical cancer cases are expected to rise 25 percent as well over the next 13 years.
Cancer could become the second leading cause of death among women with one out of seven cases predicted to be responsible for cause of death among females by 2030. This means that a woman’s lifestyle and behavior related to health and wellness is key in whether or not cancer will impact her life. Access to treatment and early diagnosis will also be an important factor in whether or not an oncology team will be able to save a woman’s life.
The results also showed that less developed nations are likely to be the ones with the most cases of breast and cervical cancer deaths. One of the studies published in The Lancet stated that 85 percent of women predicted to be diagnosed with cervical cancer will come from low- and middle-income nations.
The studies showed a number of factors that are increasing the risk of cancer among women including obesity, poor diets, and a lack of preventive capabilities whether that includes early diagnostic testing or nutrition and fitness counseling. For example, HPV vaccines can be used to prevent cervical cancer among women.
“Cancer has not been thought to be a problem really in the developing world,” Sally Cowal, senior VP of global health at ACS, told PBS NewsHour. “We have not been paying attention to the burden of cancer in terms of women’s health. It’s really much higher than we had thought it was.”
This is why creating preventive measures such as cancer vaccines is so necessary in today’s climate. With cancer rates predicted to rise, creating immunotherapies and cancer vaccines is vital. At the Cleveland Clinic Lerner Research Institute, Dr. Vincent Tuohy and his team are conducting clinical trials to determine if a breast cancer vaccine found to be 100 percent effective in preventing the disease in mice is just as safe and effective in women.
“We came up with this idea in 2002 when we realized we have this enormous deficiency in our healthcare system,” Tuohy told Prevention.com. “We have a wonderful childhood vaccine program that protects us. Yet we reach our adult years and face all these adult-onset cancers like breast cancer, ovarian cancer and prostate cancer.”